Partner James Klaiber, a member of Pryor Cashman’s Intellectual Property Group, Co-Chaired and spoke at the N.Y. City Bar Association event Patents vs. Antitrust Laws in the 21st Century, co-sponsored by the Antitrust and Trade Regulation and Patent Law association committees. The event was held on June 8, 2012.

Klaiber covered a variety of topics, including:

• How can the ability of parties to settle an action for patent infringement be reconciled with the Federal Trade Commission's focus on preventing what the Commission terms "pay-for-delay" settlements of drug patent litigations?
• Why is the Department of Justice investigating the $4.5 billion sale of Nortel's patent portfolio?
• What forms of "tying" constitute valid antitrust defenses to patent enforcement after the Federal Circuit's en-banc Princo decision?
• What is the effect of the Therasense decision on Walker Process claims?